BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6177167)

  • 1. Effect on plasma cortisol level and urinary cortisol excretion, in healthy volunteers, after application of three different topical steroid ointments under occlusion.
    Scott M; Malmsten LA; Thelin I
    Acta Derm Venereol; 1981; 61(6):543-6. PubMed ID: 6177167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of glucocorticosteroids with enhanced ratio between topical and systemic effects.
    Thalén A; Brattsand R; Andersson PH
    Acta Derm Venereol Suppl (Stockh); 1989; 151():11-9; discussion 47-52. PubMed ID: 2624062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
    Gomez EC; Kaminester L; Frost P
    Arch Dermatol; 1977 Sep; 113(9):1196-202. PubMed ID: 332089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma cortisol studies with 0.05% halometasone cream and ointment in patients with psoriasis.
    Tomasini C; Castiglioni G
    J Int Med Res; 1983; 11 Suppl 1():38-42. PubMed ID: 6832467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of efficacy and effect on plasma cortisol levels of micronised desonide cream 0.1 p. 100 versus betamethasone dipropionate cream 0.05 p. 100 In the treatment of childhood atopic dermatitis].
    Lebrun-Vignes B; Legrain V; Amoric J; Taïeb A
    Ann Dermatol Venereol; 2000; 127(6-7):590-5. PubMed ID: 10930856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic side-effects of three topical steroids in diseased skin.
    Salde L; Lassus A
    Curr Med Res Opin; 1983; 8(7):475-80. PubMed ID: 6226490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between two non-halogenated glucocorticoid ointments in psoriasis.
    Heijer A; Hesser G; Holm P; Salde L
    J Int Med Res; 1981; 9(4):239-47. PubMed ID: 7021260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
    Serup J; Holm P
    Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of an oral contraceptive on the plasma levels of budesonide and prednisolone and the influence on plasma cortisol.
    Seidegård J; Simonsson M; Edsbäcker S
    Clin Pharmacol Ther; 2000 Apr; 67(4):373-81. PubMed ID: 10801246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic effect of diflucortolone valerate after dermal application (author's transl)].
    Wendt H; Reckers R
    Arzneimittelforschung; 1976; 26(7b):1509-13. PubMed ID: 188429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The anti-inflammatory effect of a combination of dimethindene maleate and betamethasone in topical formulations].
    Lücker PW; Venitz J; Hennings G; Rehn D; Albrecht H; Alcorn G
    Arzneimittelforschung; 1985; 35(2):539-42. PubMed ID: 4039577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent effect of topical corticosteroids on blood flow in human cutaneous tissue.
    Kristensen JK; Wadskov S; Henriksen O
    Acta Derm Venereol; 1978; 58(2):145-8. PubMed ID: 76394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro release of betamethasone dipropionate from petrolatum-based ointments.
    Zatz JL; Varsano J; Shah VP
    Pharm Dev Technol; 1996 Oct; 1(3):293-8. PubMed ID: 9552312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the systemic effects of inhaled glucocorticosteroids: the influence of blood sampling technique and frequency on plasma cortisol and leucocytes.
    Jennings BH; Andersson KE; Johansson SA
    Eur J Clin Pharmacol; 1990; 39(2):127-31. PubMed ID: 2253661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plethysmographic recordings of skin pulses. VI. Further measurements of the vasoconstriction produced by corticosteroids.
    Thune P
    Acta Derm Venereol; 1972; 52(4):303-7. PubMed ID: 4115885
    [No Abstract]   [Full Text] [Related]  

  • 16. Objective measurement of topically applied corticosteroids.
    Király K; Soós G
    Dermatologica; 1976; 152 Suppl 1():133-7. PubMed ID: 955233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Percutaneous absorption of triamcinolone 16 alpha, 17 alpha cyclopentylene-dioxy-21-acetate (author's transl)].
    Meynadier J; Guilhou JJ; Peyron JL
    Dermatologica; 1981; 162(5):336-41. PubMed ID: 7250468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro effects of glucocorticosteroids on arachidonic acid metabolism and monocyte function in nonasthmatic humans.
    Manso G; Baker AJ; Taylor IK; Fuller RW
    Eur Respir J; 1992 Jun; 5(6):712-6. PubMed ID: 1321056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man.
    Johansson SA; Andersson KE; Brattsand R; Gruvstad E; Hedner P
    Eur J Clin Pharmacol; 1982; 22(6):523-9. PubMed ID: 7128664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical application of potent glucocorticoids augments epidermal beta-adrenergic adenylate cyclase response in vivo.
    Kajita S; Iizuka H; Hirokawa M; Tsutsui M; Mizumoto T
    Acta Derm Venereol; 1986; 66(6):491-6. PubMed ID: 2433868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.